Skip to main content

Blackstone Inc.

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1393818 NEW YORK, NY

Position in LXEO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,194,464
-$3,791,778 QoQ
Shares Held
904,959
0.0% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Blackstone Inc. holds $185,974,784 across 43 Biotechnology names. LXEO ranks #12 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,194,464 904,959
2025-12-31 $8,986,242 904,959
2025-09-30 $7,469,482 1,124,922
2025-06-30 $4,522,186 1,124,922
2025-03-31 $4,020,400 1,158,617
2024-12-31 $7,623,699 1,158,617
2024-09-30 $10,473,897 1,158,617
2024-06-30 $12,924,342 805,757
2024-03-31 $10,915,004 696,110
2023-12-31 $9,341,796 696,110